Histopathological and Neuropharmacological Aspects of Malignant Hyperpyrexia

Overview

Journal Proc R Soc Med

Specialty General Medicine

Date 1973 Jan 1

PMID 4690061

Citations 8

Authors

F R Ellis

N P Keaney

D G Harriman

Affiliations

Soon will be listed here.

Citing Articles

Basal bioenergetic abnormalities in skeletal muscle from ryanodine receptor malignant hyperthermia-susceptible R163C knock-in mice.

Giulivi C, Ross-Inta C, Omanska-Klusek A, Napoli E, Sakaguchi D, Barrientos G J Biol Chem. 2010; 286(1):99-113.

PMID: 20978128 PMC: 3013050. DOI: 10.1074/jbc.M110.153247.

A rat model of spontaneous myopathy and malignant hyperthermia.

Gonzalez L, Gregson N, File S Am J Pathol. 1998; 152(4):1099-103.

PMID: 9546371 PMC: 1858230.

Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia.

Britt B, Frodis W, Scott E, Clements M, Endrenyi L Can Anaesth Soc J. 1982; 29(6):550-62.

PMID: 7139394 DOI: 10.1007/BF03007740.

Malignant hyperthermia: an investigation of five patients.

Britt B, KALOW W, Gordon A, HUMPHREY J, Rewcastle N Can Anaesth Soc J. 1973; 20(4):431-67.

PMID: 4718353 DOI: 10.1007/BF03026208.

Central-core disease and malignant hyperpyrexia.

Harriman D, Ellis F Br Med J. 1973; 1(5852):545-6.

PMID: 4692683 PMC: 1588736. DOI: 10.1136/bmj.1.5852.545-a.

References

KALOW W, Britt B, Terreau M, Haist C . Metabolic error of muscle metabolism after recovery from malignant hyperthermia. Lancet. 1970; 2(7679):895-8. DOI: 10.1016/s0140-6736(70)92069-6. View

Ellis F, Harriman D, Keaney N, Tyrrell J . Halothane-induced muscle contracture as a cause of hyperpyrexia. Br J Anaesth. 1971; 43(7):721-2. View